Jaffar Raza, MD
Interventional Cardiology · Secaucus, NJNPI 1326119637
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (34.8%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Medtronic at 35.2% of the total.
Across 412 payments — averaging $109.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$16K
- Abbott$13K
- Recor Medical Inc$9K
- Boston Scientific$2K
- Cook Incorporated$591
- Amgen$486
- plus $5K from 28 others
Across 18 payments — averaging $27,343 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cleerly, Inc.$492K
What the payments were for
- Consulting fees$7,81917%
- Speaking & faculty fees$7,40016%
- Travel & lodging$13,96631%
- Food & beverage$15,64935%
- Education$1130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 71 | $15,840 |
| Abbott | 111 | $12,534 |
| Recor Medical Inc | 16 | $8,836 |
| Boston Scientific | 20 | $2,005 |
| Cook Incorporated | 3 | $591 |
| Amgen | 21 | $486 |
| Cardiovascular Systems Inc. | 12 | $474 |
| Novartis | 38 | $462 |
| Philips North America LLC | 10 | $427 |
| Cook Medical LLC | 2 | $366 |
| Merck | 24 | $365 |
| Cvrx, Inc. | 3 | $353 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $286 |
| Heartflow, Inc. | 8 | $237 |
| Impulse Dynamics (USA) Inc. | 1 | $194 |
| Terumo Medical Corporation | 4 | $180 |
| Boehringer Ingelheim | 11 | $161 |
| Abiomed | 4 | $160 |
| Shockwave Medical, Inc | 8 | $155 |
| AstraZeneca | 5 | $137 |
| Edwards Lifesciences | 1 | $130 |
| Vivaquant Inc, Dba Rhythm Express | 2 | $110 |
| Johnson & Johnson | 7 | $94 |
| Amarin Pharma, Inc. | 4 | $59 |
| Cardinal Health 200 LLC | 2 | $56 |
| Pfizer | 3 | $44 |
| Lundbeck LLC | 3 | $43 |
| Tactile Systems Technology Inc | 1 | $30 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Cordis US CORP. | 1 | $26 |
| Lantheus Medical Imaging, Inc. | 1 | $24 |
| Biocompatibles, Inc. | 1 | $22 |
| Biotronik Inc. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Paradise Ultrasound Renal Denervation System$8,562
- Xience V coronary stent system$4,232
- ClosureFast$2,918
- VenaSeal$2,100
- OMNILINK ELITE$1,525
- Omnilink Elite vascular stent system$1,326
- PERCLOSE PROGLIDE$1,168
- Watchman$1,037
- Cook Celect$910
- Resolute$661
- SUPERA$518
- Barostim Neo System$317
- ONYX FRONTIER$300
- Confirm Rx$296
- SYNERGY$235
- OPTIMIZER$194
- GENERAL - THERAPIES$172
- QUADRA ASSURA$168
- COREVALVE EVOLUT R$165
- Fortify Assura$153
How this compares
$44,946 in reported general payments places this provider in the 85th percentile of 166 interventional cardiology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 115 | $117,575 |
| EntrestoSacubitril/Valsartan | 90 | $117,043 |
| XareltoRivaroxaban | 58 | $59,919 |
| BrilintaTicagrelor | 38 | $35,635 |
| JardianceEmpagliflozin | 23 | $29,492 |
| Repatha SureclickEvolocumab | 11 | $8,333 |
| BystolicNebivolol Hcl | 13 | $4,611 |
| Rosuvastatin Calcium | 218 | $4,466 |
| ClopidogrelClopidogrel Bisulfate | 330 | $4,444 |
| Atorvastatin Calcium | 371 | $4,382 |
| Metoprolol Succinate | 251 | $3,587 |
| Nifedipine ErNifedipine | 146 | $3,482 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 78 | $2,665 |
| Amlodipine Besylate | 336 | $2,561 |
| Ranolazine ErRanolazine | 13 | $2,422 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $44 | $117,575115 claims |
| NovartisEntresto | $462 | $117,04390 claims |
| Johnson & JohnsonXarelto | $94 | $59,91958 claims |
| AstraZenecaBrilinta | $137 | $35,63538 claims |
| Boehringer IngelheimJardiance | $161 | $29,49223 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 166 interventional cardiology providers in New Jersey.
Other interventional cardiology in Secaucus
- Ankitkumar PatelGlen Ridge$408K
- Ziad AbbudOcean$360K
- Ramin HastingsHasbrouck Heights$295K
- Michael LimHackensack$215K
- Darshan GodkarCedar Knolls$194K
- Ryan KapleHackensack$178K
- Matthew SayboltEatontown$175K
- Daniel KissEatontown$172K
- Kintur SanghviBordentown$139K
- Dimitrios KarmpaliotisMorristown$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.